Loading...
Header Logo
Keywords
Last Name
Institution

William V Walsh MD

TitleAssociate Professor
InstitutionUniversity of Massachusetts Medical School
DepartmentMedicine
AddressUniversity of Massachusetts Medical School
55 Lake Avenue North
Worcester MA 01655
Phone508-334-5141
vCardDownload vCard
    Other Positions
    InstitutionUMMS - School of Medicine
    DepartmentMedicine
    DivisionHematology Oncology


    Collapse Biography 
    Collapse education and training
    Harvard University, Cambridge, MA, United StatesABBiochemical Sciences
    George Washington University School of Medicine, Washington, DC, United StatesMDMedicine

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Furtado VF, Saini NY, Walsh W, Bathini V, Miron PM. Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm. Mol Cytogenet. 2018; 11:56. PMID: 30377450.
      View in: PubMed
    2. Salhab M, Migdady Y, Donahue M, Xiong Y, Dresser K, Walsh W, Chen BJ, Liebmann J. Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience. J Immunother Cancer. 2018 May 29; 6(1):42. PMID: 29843803.
      View in: PubMed
    3. Varlotto JM, McKie K, Voland RP, Flickinger JC, DeCamp MM, Maddox D, Rava PS, Fitzgerald TJ, Walsh W, Oliveira P, Rassaei N, Baima J, Uy K. The Role of Race and Economic Characteristics in the Presentation and Survival of Patients With Surgically Resected Non-Small Cell Lung Cancer. Front Oncol. 2018; 8:146. PMID: 29868470.
      View in: PubMed
    4. Varlotto JM, Voland R, McKie K, Flickinger JC, DeCamp MM, Maddox D, Rava P, Fitzgerald TJ, Graeber G, Rassaei N, Oliveira P, Ali S, Belani C, Glanzman J, Wakelee HA, Patel M, Baima J, Zhang J, Walsh W. Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease. Cancer Med. 2018 Apr; 7(4):1211-1220. PMID: 29533006.
      View in: PubMed
    5. Li T, Piperdi B, Walsh WV, Kim M, Beckett LA, Gucalp R, Haigentz M, Bathini VG, Wen H, Zhou K, Pasquinelli PB, Gajavelli S, Sreedhara M, Xie X, Lara PN, Gandara DR, Perez-Soler R. Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer. Clin Lung Cancer. 2017 Jan; 18(1):60-67. PMID: 27919627.
      View in: PubMed
    6. Cetin V, Piperdi B, Bathini V, Walsh WV, Yunus S, Tseng JF, Whalen GF, Wassef WY, Kadish SP, Fitzgerald TJ, Mikule C, Wang Y, Grossman SR. A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma. Gastrointest Cancer Res. 2013 Jul; 6(4 Suppl 1):S2-9. PMID: 24312684.
      View in: PubMed
    7. Piperdi B, Walsh WV, Bradley K, Zhou Z, Bathini V, Hanrahan-Boshes M, Hutchinson L, Perez-Soler R. Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer. J Thorac Oncol. 2012 Jun; 7(6):1032-40. PMID: 22534815.
      View in: PubMed
    For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
    Walsh's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _